Doximity, Inc.
DOCS
$57.33
-$1.42-2.42%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 570.40M | 550.17M | 516.85M | 493.63M | 475.42M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 570.40M | 550.17M | 516.85M | 493.63M | 475.42M |
| Cost of Revenue | 55.87M | 53.97M | 51.98M | 51.07M | 50.67M |
| Gross Profit | 514.53M | 496.19M | 464.87M | 442.56M | 424.75M |
| SG&A Expenses | 190.70M | 183.84M | 176.00M | 170.87M | 170.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 339.62M | 326.20M | 313.89M | 304.56M | 302.66M |
| Operating Income | 230.78M | 223.97M | 202.96M | 189.07M | 172.77M |
| Income Before Tax | 263.57M | 253.13M | 226.33M | 203.85M | 185.20M |
| Income Tax Expenses | 40.39M | 51.79M | 52.22M | 43.30M | 37.62M |
| Earnings from Continuing Operations | 223.19 | 201.35 | 174.11 | 160.55 | 147.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 223.19M | 201.35M | 174.11M | 160.55M | 147.58M |
| EBIT | 230.78M | 223.97M | 202.96M | 189.07M | 172.77M |
| EBITDA | 235.64M | 228.85M | 207.89M | 194.19M | 178.03M |
| EPS Basic | 1.19 | 1.08 | 0.93 | 0.86 | 0.78 |
| Normalized Basic EPS | 0.89 | 0.86 | 0.77 | 0.71 | 0.64 |
| EPS Diluted | 1.11 | 1.00 | 0.87 | 0.80 | 0.72 |
| Normalized Diluted EPS | 0.83 | 0.80 | 0.72 | 0.66 | 0.59 |
| Average Basic Shares Outstanding | 747.39M | 745.78M | 744.93M | 751.79M | 760.70M |
| Average Diluted Shares Outstanding | 804.85M | 802.97M | 801.20M | 809.81M | 822.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |